A system dynamics decision support tool for bioproduct industry stakeholders who want to investigate how their decisions can impact the process of bioproducts gaining U.S. market share.
If advertising effectiveness is too high (more than ca. 0.0005, but depends on the value of advertising spending), advertising impact spikes when advertising spending kicks in and then rebounds to a negative value, which can drive NonAdopters negative. In this scenario Potential Adopters and Adopters do not go negative.
Replacing NonAdopters in advertising impact and word of mouth impact with MAX(0, NonAdopters) only keeps NonAdopters negative after the spike.
advertising impact and word of mouth impact should have maxima set based on the current value of NonAdopters
Resolve by adding a MIN() structure to word of mouth impact and advertising impact, such that these parameters will return the minimum of their calculated value or NonAdopters / TIME STEP. The resulting behavior is that if either impact becomes too high, it maxes out to drain NonAdopters in the next time step and NonAdopters goes to zero instead of going negative.
If
advertising effectiveness
is too high (more than ca. 0.0005, but depends on the value ofadvertising spending
),advertising impact
spikes whenadvertising spending
kicks in and then rebounds to a negative value, which can driveNonAdopters
negative. In this scenarioPotential Adopters
andAdopters
do not go negative.Replacing
NonAdopters
inadvertising impact
andword of mouth impact
with MAX(0,NonAdopters
) only keepsNonAdopters
negative after the spike.advertising impact
andword of mouth impact
should have maxima set based on the current value ofNonAdopters
Resolve by adding a MIN() structure to
word of mouth impact
andadvertising impact
, such that these parameters will return the minimum of their calculated value orNonAdopters
/TIME STEP
. The resulting behavior is that if either impact becomes too high, it maxes out to drainNonAdopters
in the next time step andNonAdopters
goes to zero instead of going negative.